Global Calcineurin Inhibitor Market Value to Climb to USD 12.5 Billion by 2032
Global Calcineurin Inhibitor Market Value to Climb to USD 12.5 Billion by 2032 Market Expected to Achieve a 3.3% CAGR as Biosimilar Competition and Advanced Drug Delivery Methods Drive Accessibility The global Calcineurin Inhibitor (CNI) Market, highlighting the sustained demand for these critical immunosuppressive drugs. The market, which secured a valuation of USD 9.34 Billion in 2023, is...
0 Комментарии 0 Поделились 3 Просмотры 0 предпросмотр